1999
DOI: 10.1093/mutage/14.4.403
|View full text |Cite
|
Sign up to set email alerts
|

A micromethod for the in vitro micronucleus assay

Abstract: A micromethod for the in vitro micronucleus assay was developed using L5178Y cells to enable the rapid screening of a large number of molecules. The method is quick, simple to perform and needs very small amounts of compound, i.e. <10 mg. In this methodology, three types of treatment were carried out in parallel, enabling an optimal detection of both aneugenic and clastogenic compounds: two treatments without metabolic activation with or without a recovery period after a 24 h continuous treatment and one treat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2005
2005
2018
2018

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 54 publications
(16 citation statements)
references
References 36 publications
0
16
0
Order By: Relevance
“…The in vitro micronucleus assay was performed according the procedure described by Nesslany and Marzin (1999). This micro-method used mouse lymphoma cells L5178Y.…”
Section: Aquatic (Geno)toxicity Testsmentioning
confidence: 99%
“…The in vitro micronucleus assay was performed according the procedure described by Nesslany and Marzin (1999). This micro-method used mouse lymphoma cells L5178Y.…”
Section: Aquatic (Geno)toxicity Testsmentioning
confidence: 99%
“…This test consisted in an in vitro micronucleus test using mice lymphoma cells (Nesslany and Marzin, 1999). This test was carried out by Pasteur Institute (Lille, FRANCE).…”
Section: Toxicity Of Soils and Aliquotsmentioning
confidence: 99%
“…These characteristics have led to its widespread use as an efficient and relatively simple method to screen drug candidates and other test articles for clastogenic and aneugenic potentials [Nesslany and Marzin, 1999]. Furthermore, there have been concerted efforts to establish robust protocols so that the in vitro micronucleus test can serve as a source of cytogenetic damage information for regulatory submission purposes in place of in vitro chromosome aberration results von der Hude et al, 2000;Garriott et al, 2002;Phelps et al, 2002;KirschVolders et al, 2003].…”
Section: Introductionmentioning
confidence: 99%